GSK-2831781

N/A

Report date: 2025/01/21 17:01:27

Base Information

Drug NameGSK-2831781
Drug Alias NameImmuTune-IMP731GSK-2831781GSK‘-781IMP-731
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionLymphocyte activation gene 3 protein inhibitorsCytotoxic T lymphocytes inhibitors
TargetsLymphocyte activation gene 3 protein
Therapy Area/IndicationsPsoriasisColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaUnited States +[16] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesImmutep Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcImmutep Ltd
Active IndicationsN/A
Inactive IndicationsPsoriasisColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksWikipedia